These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3244442)

  • 1. Characterization of a murine model for human bismuth encephalopathy.
    Ross JF; Sahenk Z; Hyser C; Mendell JR; Alden CL
    Neurotoxicology; 1988; 9(4):581-6. PubMed ID: 3244442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highest brain bismuth levels and neuropathology are adjacent to fenestrated blood vessels in mouse brain after intraperitoneal dosing of bismuth subnitrate.
    Ross JF; Broadwell RD; Poston MR; Lawhorn GT
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):191-200. PubMed ID: 8122264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuropathologic and toxicologic study of 12 cases of bismuth encephalopathy].
    Escourolle R; Bourdon R; Galli A; Galle P; Jaudon MC; Hauw JJ; Gray F
    Rev Neurol (Paris); 1977 Mar; 133(3):153-63. PubMed ID: 918459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bismuth encephalopathy in pregnant women. Apropos of a case].
    Quéreux C; Morice J; Level G; Ezes H; Wahl P
    J Gynecol Obstet Biol Reprod (Paris); 1976; 5(1):97-103. PubMed ID: 956618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reversible encephalopathies caused by bismuth salts. 5 further cases].
    Lhermitte F; Degos CF; Signoret JL
    Nouv Presse Med; 1975 Feb; 4(6):419-20. PubMed ID: 1129094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bismuth encephalopathy].
    Krüger G
    Fortschr Neurol Psychiatr; 1984 Jan; 52(1):24-31. PubMed ID: 6698481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bismuth encephalopathy.
    Monseu G; Struelens M; Roland M
    Acta Neurol Belg; 1976; 76(5-6):301-8. PubMed ID: 1007897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and electroencephalographic correlates in bismuth-induced myoclonic encephalopathy].
    Gastaut JL; Jouglard J
    Therapie; 1980; 35(3):293-6. PubMed ID: 7423414
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bismuth myoclonic encephalopathies. Their course and lasting or definitive late complications].
    Buge A; Rancurel G; Dechy H
    Rev Neurol (Paris); 1977; 133(6-7):401-15. PubMed ID: 929035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of bismuth toxicity by l-cysteine.
    Krari N; Mauras Y; Allain
    Res Commun Mol Pathol Pharmacol; 1995 Sep; 89(3):357-64. PubMed ID: 8680804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Letter: Myoclonic encephalopathy and bismuth salt poisoning].
    Cambier J; Mason M; Dairou R
    Nouv Presse Med; 1974 Dec; 3(44):2662. PubMed ID: 4459861
    [No Abstract]   [Full Text] [Related]  

  • 12. [The bismuth-encephalopathy - a new pathological syndrome (author's transl)].
    Eichler I
    Wien Klin Wochenschr; 1979 Apr; 91(9):314-20. PubMed ID: 109997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Encephalopathy during oral treatment with bismuth salts].
    Michaud PA; Regli F
    Schweiz Med Wochenschr; 1976 Apr; 106(16):550-5. PubMed ID: 988634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus.
    Gordon MF; Abrams RI; Rubin DB; Barr WB; Correa DD
    Mov Disord; 1995 Mar; 10(2):220-2. PubMed ID: 7753066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myoclonic encephalopathy due to ingestion of insoluble salts of bismuth].
    Cambier J; Dairou R
    Arch Fr Mal App Dig; 1975; 64(1):5-9. PubMed ID: 1164144
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute neurologic decompression illness in pigs: lesions of the spinal cord and brain.
    Dick EJ; Broome JR; Hayward IJ
    Lab Anim Sci; 1997 Feb; 47(1):50-7. PubMed ID: 9051647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myoclonic encephalopathy caused by bismuth salts. Efficacy of treatment with dimercaprol].
    Molina JA; Calandre L; Bermejo F; Posadas F; Fernández-Ortega JD
    Med Clin (Barc); 1989 Jun; 93(1):20-2. PubMed ID: 2770373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of endogenous interleukin-10 on gray matter damage and the development of pain behaviors following excitotoxic spinal cord injury in the mouse.
    Abraham KE; McMillen D; Brewer KL
    Neuroscience; 2004; 124(4):945-52. PubMed ID: 15026134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myoclonic encephalopathy caused by bismuth].
    Nogué Xarau S; Sanz Gallén P
    Rev Clin Esp; 1990 Feb; 186(3):145. PubMed ID: 2356356
    [No Abstract]   [Full Text] [Related]  

  • 20. [The intracerebral distribution of bismuth in bismuth encephalopathy. Pathological and toxicological study of 3 cases (author's transl)].
    Ribadeau Dumas JL; Lechevalier B; Breteau M; Allain Y
    Nouv Presse Med; 1978 Dec; 7(44):4021-5. PubMed ID: 733570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.